全文获取类型
收费全文 | 568篇 |
免费 | 63篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 43篇 |
妇产科学 | 2篇 |
基础医学 | 78篇 |
口腔科学 | 13篇 |
临床医学 | 55篇 |
内科学 | 151篇 |
皮肤病学 | 5篇 |
神经病学 | 44篇 |
特种医学 | 14篇 |
外科学 | 78篇 |
综合类 | 17篇 |
预防医学 | 57篇 |
眼科学 | 3篇 |
药学 | 34篇 |
肿瘤学 | 31篇 |
出版年
2021年 | 10篇 |
2020年 | 9篇 |
2019年 | 18篇 |
2018年 | 21篇 |
2017年 | 6篇 |
2016年 | 5篇 |
2015年 | 10篇 |
2014年 | 7篇 |
2013年 | 21篇 |
2012年 | 25篇 |
2011年 | 27篇 |
2010年 | 23篇 |
2009年 | 12篇 |
2008年 | 24篇 |
2007年 | 29篇 |
2006年 | 19篇 |
2005年 | 26篇 |
2004年 | 17篇 |
2003年 | 23篇 |
2002年 | 15篇 |
2001年 | 16篇 |
2000年 | 11篇 |
1999年 | 18篇 |
1998年 | 7篇 |
1997年 | 4篇 |
1996年 | 5篇 |
1995年 | 8篇 |
1993年 | 5篇 |
1992年 | 14篇 |
1991年 | 5篇 |
1990年 | 16篇 |
1989年 | 13篇 |
1988年 | 8篇 |
1987年 | 13篇 |
1986年 | 8篇 |
1985年 | 5篇 |
1983年 | 6篇 |
1982年 | 4篇 |
1979年 | 17篇 |
1978年 | 12篇 |
1977年 | 4篇 |
1976年 | 5篇 |
1975年 | 6篇 |
1974年 | 4篇 |
1973年 | 7篇 |
1972年 | 7篇 |
1971年 | 4篇 |
1969年 | 5篇 |
1968年 | 11篇 |
1967年 | 12篇 |
排序方式: 共有631条查询结果,搜索用时 15 毫秒
1.
R.P. Butt J.P. Huggins D. Greiling B. Hopkins S. Gaboardi D. Winslow M. Ronald S. Lewis S. Ward E. Levett J. Owen F. Burslem M. Collis S. Bailey P.V. Fish G. Whitlock S. Billotte K. James A. Mcelroy J. Blagg 《International journal of experimental pathology》2004,85(1):A20-A21
Introduction Fibrosis is a component of many tissue pathologies leading to loss of normal tissue function, primarily due to excessive collagen deposition. Collagen is deposited following cleavage of the C- and N- terminal peptides from the pro-collagen molecule. The cleavage of the globular C-peptide by PCP reduces solubility of the fibrillar collagen molecule, resulting in deposition of insoluble collagen. Increased insoluble collagen deposition is a feature of all organ fibroses, with inhibition of this process, a key potential anti-fibrotic mechanism. The aim of this work was to discover potent and selective PCP inhibitors as experimental, topically applied, anti-fibrotic drugs for clinical evaluation.
Materials and methods PCP was cloned from human osteosarcoma cells and enzymatic activity demonstrated using a PCP-specific peptide cleavage assay. Activities were confirmed by measuring cleavage of [3 H]C-peptide from type-I pro-collagen. A cell-based fibroplasias model was employed to demonstrate compound efficacy using collagen deposition, liberated C-peptide and histological endpoints. The activities of PCP inhibitors in fibroblast and epithelial in vitro cell proliferation and migration assays, and selectivity vs. a panel of MMPs were also determined.
Discussion In summary, we have identified and characterized potent and selective inhibitors of PCP for progression to clinical studies for investigation as a treatment paradigm for fibrotic disease.
Materials and methods PCP was cloned from human osteosarcoma cells and enzymatic activity demonstrated using a PCP-specific peptide cleavage assay. Activities were confirmed by measuring cleavage of [
Discussion In summary, we have identified and characterized potent and selective inhibitors of PCP for progression to clinical studies for investigation as a treatment paradigm for fibrotic disease.
Results 相似文献
2.
3.
H D White J T Rivers A H Maslowski J A Ormiston M Takayama H H Hart D N Sharpe R M Whitlock R M Norris 《The New England journal of medicine》1989,320(13):817-821
In a double-blind trial comparing two thrombolytic agents as treatment for acute myocardial infarction, we randomized 270 consecutive patients an average (+/- SD) of 2.5 +/- 0.6 hours after the onset of chest pain from a first myocardial infarction--135 to receive intravenous streptokinase (1.5 million units over 30 minutes) and 135 to receive intravenous recombinant tissue plasminogen activator (rt-PA) (100 mg over three hours). The primary end point was left ventricular function as assessed by cineangiography performed three weeks after infarction. The effects of the two agents on left ventricular function were similar. The ejection fraction was identical (58 +/- 12 percent) in both groups. The end-systolic volume was 61 +/- 29 ml in the streptokinase group and 66 +/- 31 ml in the rt-PA group (P not significant). Patency rates at three weeks for the infarct-related artery were also similar (75 percent in the streptokinase group and 76 percent in the rt-PA group). Reinfarction rates at 30 days were the same (5 percent) in both groups. One patient had a fatal intracerebral hemorrhage 13 hours after receiving rt-PA, and another had a fatal cerebellar hemorrhage 21 hours after receiving rt-PA for reinfarction nine days after treatment with streptokinase. An intention-to-treat analysis revealed that mortality at 30 days was 3.7 percent in the rt-PA group as compared with 7.4 percent in the streptokinase group (P greater than 0.2). Follow-up for a mean of 9.0 months revealed no significant difference in survival; we observed 12 deaths (8.9 percent) in the streptokinase group and 8 deaths (5.9 percent) in the rt-PA group (P = 0.34). We conclude that rt-PA and streptokinase, in the doses given, have similar effects on left ventricular function after a first myocardial infarction. Because of the small number of deaths, it is not possible to determine whether their effects on mortality are similar. 相似文献
4.
5.
Dixon SR Ruygrok PN Agnew TM Lund M Aldersley PF Gibbs HC Whitlock RM Haydock DA Coverdale HA 《The New Zealand medical journal》1999,112(1099):417-420
AIMS: To determine the prevalence of cardiac allograft vasculopathy in heart transplant recipients at Green Lane Hospital and to examine potential risk factors for vasculopathy. METHODS: We retrospectively reviewed the coronary angiograms of all cardiac transplant recipients. Angiography was usually performed one, two and five years after operation. The diagnosis of allograft vasculopathy was made if there was any evidence of coronary artery disease. Patients' medical records were reviewed for potential risk factors. RESULTS: Ninety-one patients underwent cardiac transplantation between December 1987 and March 1998. One year survival was 87%. Angiographic evidence of coronary disease was present in 30 patients and in three patients coronary lesions were first identified at post mortem. Vasculopathy was present in 25%, 35% and 61% of patients at one two and five years following transplant. Donor-acquired lesions could not be excluded as few patients had immediate postoperative angiograms for comparison. Five late deaths have been due to vasculopathy. Recipient age, race, donor age and ischaemic time were similar for those with and without vasculopathy. Frequency or severity of acute rejection episodes, cytomegalovirus infection, lipid profiles, diabetes and hypertension were not significantly different in patients with vasculopathy. CONCLUSION: Cardiac allograft vasculopathy is a common finding after heart transplantation. No definite risk factors were identified in this patient group. 相似文献
6.
Biology of tooth replacement in amniotes 总被引:1,自引:0,他引:1
Tooth replacement is a common trait to most vertebrates, including mammals. Mammals, however, have lost the capacity for continuous tooth renewal seen in most other vertebrates, and typically have only 1–2 generations of teeth. Here, we review the mechanisms of tooth replacement in reptiles and mammals, and discuss in detail the current and historical theories on control of timing and pattern of tooth replacement and development. 相似文献
7.
8.
Pandey Arjun K. Xu Ke Zhang Li Gupta Saurabh Eikelboom John Lopes Renato D. Crowther Mark Belley-Côté Emilie P. Whitlock Richard P. 《Journal of thrombosis and thrombolysis》2022,53(3):697-707
Journal of Thrombosis and Thrombolysis - The optimal INR target in patients with mechanical heart valves is unclear. Higher INR targets are often used in Western compared with East Asian countries.... 相似文献
9.
Cellular immune responses to platelet factor 4 and heparin complexes in patients with heparin‐induced thrombocytopenia
下载免费PDF全文
![点击此处可从《Journal of thrombosis and haemostasis》网站下载免费的PDF全文](/ch/ext_images/free.gif)
10.
O. S. El-Khatib MD O. Lebwohl MD A. A. Attia MD C. A. Flood MD J. A. Stein MD J. G. Sweeting MD R. T. Whitlock MD E. F. Osserman MD Dr. P. R. Holt MD 《Digestive diseases and sciences》1978,23(4):297-301
The serum levels of lysozyme, serum electrophoresis, and serum immunoglobulins were determined prospectively in 101 patients with ulcerative colitis, ulcerative proctitis, Crohn's disease, or nonclassifiable nonspecific inflammatory bowel disease. Although the mean serum lysozyme concentration of patients with Crohn's disease (10.5±6.8 μg/ml) and ulcerative colitis (9.6±4.1 μg/ml) performed by a standardized lysoplate method was significantly greater than normal controls (6.0±1.5 μg/ml), the results did not correlate with the diagnosis nor with the degree of disease activity. Individually separated protein fractions and serum immunoglobulins also did not correlate with the serum lysozyme levels. This study indicates that measurement of the level of serum lysozyme in individual patients is not helpful in determining the cause or degree of activity of non-specific inflammatory bowel disease. 相似文献